In a world first, a donated human liver has been ‘kept alive’ outside a human being and then successfully transplanted into a patient in need of a new liver.
So far the procedure has been performed on two patients on the liver transplant waiting list and both are making excellent recoveries.
Currently transplantation depends on preserving donor organs by putting them ‘on ice’ – cooling them to slow their metabolism. But this often leads to organs becoming damaged.
The technology, developed at Oxford and now being trialled at the University of Oxford liver transplant centre at King’s College Hospital as part of a controlled clinical investigation, could preserve a functioning liver outside the body for 24 hours. A donated human liver connected to the device is raised to body temperature and oxygenated red blood cells are circulated through its capillaries. Once on the machine, a liver functions normally just as it would inside a human body, regaining its colour and producing bile.
The results from the first two transplants, carried out at King’s College Hospital in February 2013, suggest that the device could be useful for all patients needing liver transplants. Based on pre-clinical data, the new device could also enable the preservation of livers which would otherwise be discarded as unfit for transplantation – potentially as much as doubling the number of organs available for transplant and prolonging the maximum period of organ preservation to 24 hours.
‘These first clinical cases confirm that we can support human livers outside the body, keep them alive and functioning on our machine and then, hours later, successfully transplant them into a patient,’ said Professor Constantin Coussios of Oxford University’s Department of Engineering Science, one of the machine’s inventors and Technical Director of OrganOx, the University spin-out created to bring the device from bench to bedside.
‘The device is the very first completely automated liver perfusion device of its kind: the organ is perfused with oxygenated red blood cells at normal body temperature, just as it would be inside the body, and can for example be observed making bile, which makes it an extraordinary feat of engineering.
‘It was astounding to see an initially cold grey liver flushing with colour once hooked up to our machine and performing as it would within the body. What was even more amazing was to see the same liver transplanted into a patient who is now walking around.
‘Whilst for these two transplants we only needed to keep the livers alive for up to 10 hours, in other experiments we have shown we can preserve a functioning liver and monitor its function outside the body for periods up to 24 hours.’
The Latest Bing News on:
Liver transplants
- Penn State Health halts liver transplants as national oversight body reviews programon May 1, 2024 at 1:00 am
This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated to investigative and public-service journalism for Pennsylvania. Sign up for our north-central Pa. newsletter, Talk of the Town, at ...
- Her husband died waiting on a Houston hospital’s liver transplant list. Now she intends to take legal actionon April 29, 2024 at 1:34 pm
An increasing number of Memorial Hermann patients have died while anxiously waiting on transplant lists that could've granted them life-saving organs, according to data from the Organ Procurement Transplantation Network.
The Latest Google Headlines on:
Liver transplants
[google_news title=”” keyword=”liver transplants” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Liver machine
- Video Shows Dad Accused of Killing Son, 6, Forcing Boy to Use Treadmill Because He's 'Fat': Prosecutorson May 1, 2024 at 8:50 am
The trial is underway for Christopher Gregor, a New Jersey father accused of killing his 6-year-old son Corey Micciolo after allegedly forcing the boy to run on a treadmill.
- 2 your health: new technology benefits liver transplantson April 30, 2024 at 3:41 pm
Every second counts when it comes to organ donations, and that’s why Cleveland Clinic surgeons are using new technology to help preserve livers before they’re transplanted. “Many have seen ...
- This $119 houseplant is bioengineered to remove harmful air pollution in your home.on April 30, 2024 at 2:41 pm
Neoplants has bioengineered a houseplant that uses bacteria to remove indoor air pollution from your home.
- Toxic paint stripper chemical banned from consumer useon April 30, 2024 at 9:51 am
The Environmental Protection Agency said Tuesday it has finalized a ban on consumer uses of methylene chloride, a chemical that is widely used as a paint stripper but is known to cause liver cancer ...
- Inside the class action against Philips Electronics over recall of sleep therapy machineon April 29, 2024 at 6:44 am
Exclusive: Thousands of Aussies who relied on a respiratory ventilator which was later found to have potentially released fatal particles into their lungs as they slept, are taking on a global ...
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bnon April 23, 2024 at 1:50 am
Under the terms of the agreement, Ochre will receive up to $35m in upfront and near-term research-based milestone payments, as well as possible milestones for clinical, regulatory and commercial ...
- Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnershipon April 22, 2024 at 12:48 pm
Boehringer Ingelheim will apply Ochre Bio’s discovery platform to develop treatments for late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and other chronic liver diseases ...
- Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASHon April 22, 2024 at 5:44 am
The German drugmaker is paying British biotech Ochre Bio $35 million in upfront and near-term research-based milestone payments to investigate “multiple targets” for chronic liver disease. Top of the ...
- Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver diseaseon April 22, 2024 at 3:59 am
Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease ...
- Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseaseson April 21, 2024 at 5:00 pm
Machines mimic the body’s physiological conditions ... its approach generates human-relevant data. This liver testing is conducted at a research site in New York. Germany-based Boehringer ...
The Latest Google Headlines on:
Liver machine
[google_news title=”” keyword=”liver machine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]